Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome

被引：0
|
作者：
E J Duncavage
J O'Brien
K Vij
C A Miller
G S Chang
J Shao
M A Jacoby
S Heath
M R Janke
K Elliott
R S Fulton
C Fronick
M O'Laughlin
P Westervelt
T J Ley
R K Wilson
M J Walter
机构：
[1] Washington University,Department of Pathology and Immunology
[2] Washington University School of Medicine,Division of Oncology, Department of Medicine
[3] The McDonnell Genome Institute,Department of Genetics
[4] Washington University,Division of Genomics and Bioinformatics, Department of Medicine
[5] Washington University School of Medicine,undefined
[6] Washington University in St. Louis,undefined
来源：
Leukemia | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2422 / 2426
页数：4
相关论文
共 50 条
  • [1] Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome
    Duncavage, E. J.
    O'Brien, J.
    Vij, K.
    Miller, C. A.
    Chang, G. S.
    Shao, J.
    Jacoby, M. A.
    Heath, S.
    Janke, M. R.
    Elliott, K.
    Fulton, R. S.
    Fronick, C.
    O'Laughlin, M.
    Westervelt, P.
    Ley, T. J.
    Wilson, R. K.
    Walter, M. J.
    [J]. LEUKEMIA, 2016, 30 (12) : 2422 - 2426
  • [2] Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome
    Petrova-Drus, Kseniya
    Hasserjian, Robert
    Pozdnyakova, Olga
    Dal Cin, Paola
    Mathew, Susan
    Margolskee, Elizabeth
    Orazi, Attilio
    Geyer, Julia T.
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 569 - 577
  • [3] Do patients with low-grade myelodysplastic syndrome (MDS) mobilise normal hemopoietic progenitors?
    Mijovic, A
    Delforge, M
    Sekhavat, M
    Czepulkowski, B
    Ghulam, MJ
    [J]. BLOOD, 2000, 96 (11) : 149A - 149A
  • [4] The current perspective of low-grade myelodysplastic syndrome in children
    Hasegawa, Daisuke
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (04) : 360 - 364
  • [5] The current perspective of low-grade myelodysplastic syndrome in children
    Daisuke Hasegawa
    [J]. International Journal of Hematology, 2016, 103 : 360 - 364
  • [6] Clinical Utility of Targeted Next Generation Sequencing (NGS) in the Evaluation of Low-Grade Lymphoid Malignancies
    Jajosky, Audrey
    Havens, Nathaniel
    Sadri, Navid
    Oduro, Kwadwo
    Moore, Erika
    Beck, Rose
    Meyerson, Howard
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1311 - 1313
  • [7] Clinical Utility of Targeted Next Generation Sequencing (NGS) in the Evaluation of Low-Grade Lymphoid Malignancies
    Jajosky, Audrey
    Havens, Nathaniel
    Sadri, Navid
    Oduro, Kwadwo
    Moore, Erika
    Beck, Rose
    Meyerson, Howard
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1311 - 1313
  • [8] Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders
    Jajosky, Audrey N.
    Havens, Nathaniel P.
    Sadri, Navid
    Oduro, Kwadwo A.
    Moore, Erika M.
    Beck, Rose C.
    Meyerson, Howard J.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (03) : 433 - 444
  • [9] Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype
    Wang, Wei
    Routbort, Mark J.
    Tang, Zhenya
    Ok, Chi Young
    Patel, Keyur P.
    Daver, Naval
    Garcia-Manero, Guillermo
    Medeiros, L. Jeffrey
    Wang, Sa A.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (06) : 536 - 543
  • [10] VALUE OF EPIGENETICS IN THE DEFINITION OF RISK IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH NORMAL KARYOTYPE
    Andrade Campos, M.
    Andres Coduras, M.
    Ramos, F.
    Giraldo, P.
    [J]. HAEMATOLOGICA, 2015, 100 : 187 - 188
12345